Deferred Tax Assets, Operating Loss Carryforwards of AVAI BIO, INC. from 31 Mar 2020 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
AVAI BIO, INC. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 31 Mar 2020 to 31 Mar 2025.
  • AVAI BIO, INC. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Mar 2025 was $4,118,510, a 38% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

AVAI BIO, INC. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $4,118,510 +$1,142,115 +38% 31 Mar 2025 10-K 08 Jul 2025 2025 FY
Q1 2024 $2,976,395 +$2,128,475 +251% 31 Mar 2024 10-K 08 Jul 2025 2025 FY
Q1 2023 $847,920 +$352,069 +71% 31 Mar 2023 10-K/A 19 Feb 2025 2024 FY
Q1 2022 $495,851 +$180,791 +57% 31 Mar 2022 10-K/A 13 Jul 2023 2022 FY
Q1 2021 $315,060 +$300,982 +2138% 31 Mar 2021 10-K 29 Jun 2022 2022 FY
Q1 2020 $14,078 31 Mar 2020 10-K/A 18 Aug 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.